The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseasesGOSS, C. H; MAYER-HAMBLETT, N; KRONMAL, R. A et al.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1505-1528, issn 0169-409X, 24 p.Article

An overview of the pathogenesis of cystic fibrosis lung diseaseBOUCHER, R. C.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1359-1371, issn 0169-409X, 13 p.Article

Inhaled P2Y₂ receptor agonists as a treatment for patients with Cystic Fibrosis lung diseaseDON KELLERMAN PHARMD; EVANS, Richard; MATHEWS, Dave et al.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1463-1474, issn 0169-409X, 12 p.Article

Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosisKONSTAN, Michael W; DAVIS, Pamela B.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1409-1423, issn 0169-409X, 15 p.Article

Pharmacological approaches to discovery and development of new mucolytic agentsKING, Malcolm; RUBIN, Bruce K.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1475-1490, issn 0169-409X, 16 p.Article

Current concepts on the pathophysiology and drug development in cystic fibrosisHOPKINS, S. E; BOUCHER, R. C.Advanced drug delivery reviews. 2002, Vol 54, Num 11, issn 0169-409X, 173 p.Serial Issue

Therapeutic approaches to repair defects in ΔF508 CFTR folding and cellular targetingPOWELL, Kristina; ZEITLIN, Pamela L.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1395-1408, issn 0169-409X, 14 p.Article

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targetsHASSETT, Daniel J; CUPPOLETTI, John; HWANG, Sung-Hei et al.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1425-1443, issn 0169-409X, 19 p.Article

Biochemical analysis of human immunodeficiency virus-1 reverse transcriptase containing a mutation at position lysine 263MARTIN, J. L; WILSON, J. E; FURFINE, E. S et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 4, pp 2565-2570, issn 0021-9258Article

Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acidsMAKHOUL, Z; KRISTAL, A. R; BOYER, B et al.European journal of clinical nutrition. 2011, Vol 65, Num 7, pp 808-817, issn 0954-3007, 10 p.Article

Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosisFERRARI, Stefano; GEDDES, Duncan M; ALTON, Eric W. F. W et al.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1373-1393, issn 0169-409X, 21 p.Article

Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agentsHIRSH, Andrew J.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1445-1462, issn 0169-409X, 18 p.Article

Pharmaceutical and biotechnological aerosols for cystic fibrosis therapyGARCIA-CONTRERAS, Lucila; HICKEY, Anthony J.Advanced drug delivery reviews. 2002, Vol 54, Num 11, pp 1491-1504, issn 0169-409X, 14 p.Article

Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndromeHOBBS, C. A; SHERMAN, S. L; PING YI et al.American journal of human genetics. 2000, Vol 67, Num 3, pp 623-630, issn 0002-9297Article